2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$34.94+$0.46 (+1.33%)
Price as of Sep 11, 2026 7:41 PM EDT- $1.3BMarket Cap
- -12.53%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$34.94+$0.46 (+1.33%)
Earnings Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | -0 | ||
Low Earnings Volatility | 6 |
Momentum Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 17.63% | ||
12-Month Momentum | -0.23% | ||
3-Month Risk Adjusted Momentum | 80.19% | ||
12-Month Risk Adjusted Momentum | -0.36% |
True Yield
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.02% |
Financial Health Score
Valuation | HROW | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |